Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
27 05 2021
Historique:
pubmed: 24 4 2021
medline: 22 6 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

The activation of cannabinoid CB

Identifiants

pubmed: 33887904
doi: 10.1021/acs.jmedchem.1c00484
pmc: PMC8486167
doi:

Substances chimiques

Analgesics 0
Cannabinoids 0
Peptides 0
Receptor, Cannabinoid, CB1 0
Receptor, Serotonin, 5-HT2A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6937-6948

Références

Pharmacol Rev. 2014 Feb 10;66(2):413-34
pubmed: 24515647
Eur J Pharmacol. 2018 Jan 5;818:271-277
pubmed: 29111112
J Adolesc Young Adult Oncol. 2020 Feb;9(1):30-35
pubmed: 31436482
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Eur J Pharmacol. 2017 Oct 15;813:66-83
pubmed: 28734930
J Pharm Pharm Sci. 2013;16(5):821-47
pubmed: 24393558
Nature. 1990 Aug 9;346(6284):561-4
pubmed: 2165569
ScientificWorldJournal. 2008 Oct 11;8:1088-97
pubmed: 18956124
Pain. 2016 Feb;157 Suppl 1:S23-S32
pubmed: 26785153
BMC Biol. 2020 Jan 23;18(1):9
pubmed: 31973708
Biol Psychiatry. 2012 Jan 1;71(1):84-91
pubmed: 22035699
Neuroscience. 2011 May 5;181:1-17
pubmed: 21334423
ACS Chem Biol. 2017 May 19;12(5):1257-1268
pubmed: 28263555
Pain Physician. 2017 Feb;20(2S):S93-S109
pubmed: 28226333
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3449-53
pubmed: 7724582
Nat Chem Biol. 2019 Dec;15(12):1199-1205
pubmed: 31659318
J Biol Chem. 2015 Oct 16;290(42):25728-44
pubmed: 26330551
Mol Neurobiol. 2018 Aug;55(8):6347-6361
pubmed: 29294249
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
Science. 1999 Sep 3;285(5433):1569-72
pubmed: 10477521
Addict Biol. 2008 Jun;13(2):196-212
pubmed: 18422832
Br J Pharmacol. 2006 Jun;148(4):387-95
pubmed: 16682964
Bioinformatics. 2018 Nov 15;34(22):3857-3863
pubmed: 29850769
Cell. 2016 Oct 20;167(3):750-762.e14
pubmed: 27768894
Phys Med Rehabil Clin N Am. 2014 May;25(2):457-70
pubmed: 24787343
J Headache Pain. 2018 May 24;19(1):37
pubmed: 29797104
J Med Chem. 2018 Oct 25;61(20):9335-9346
pubmed: 30257092
PLoS Biol. 2015 Jul 09;13(7):e1002194
pubmed: 26158621
Mol Ther. 2011 Oct;19(10):1849-57
pubmed: 21556052
Science. 2013 May 3;340(6132):615-9
pubmed: 23519215
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9765-9
pubmed: 7937888
Expert Opin Drug Discov. 2019 Dec;14(12):1297-1312
pubmed: 31507210
Curr Drug Targets CNS Neurol Disord. 2003 Dec;2(6):389-402
pubmed: 14683467
Curr Pharm Des. 2020;26(13):1495-1506
pubmed: 32053069
Adv Pharmacol. 2020;88:1-33
pubmed: 32416864
Life Sci. 2005 Aug 19;77(14):1667-73
pubmed: 15978631
J Nanobiotechnology. 2017 Apr 28;15(1):34
pubmed: 28454579
Annu Rev Pharmacol Toxicol. 2016;56:403-25
pubmed: 26514203
Schizophr Bull. 2020 Dec 1;46(6):1547-1557
pubmed: 32249318
J Biol Chem. 2017 Jan 20;292(3):847-861
pubmed: 27923812
Angew Chem Int Ed Engl. 2015 Mar 23;54(13):3967-72
pubmed: 25650865
Br J Pharmacol. 2002 Jan;135(2):564-78
pubmed: 11815392
J Pharmacol Exp Ther. 1996 Jan;276(1):56-64
pubmed: 8558457
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3254-63
pubmed: 23108544
Front Bioeng Biotechnol. 2020 Sep 09;8:552035
pubmed: 33015016
Front Neurosci. 2013 Dec 20;7:256
pubmed: 24391536
Trends Neurosci. 1990 Oct;13(10):420-3
pubmed: 1700516
Handb Exp Pharmacol. 2005;(168):509-54
pubmed: 16596786
Pain. 2015 Oct;156(10):2001-2012
pubmed: 26067584
Int J Mol Sci. 2019 Oct 05;20(19):
pubmed: 31590403
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
Br J Pharmacol. 2010 Jun;160(3):627-42
pubmed: 20590567
Cell. 2017 Jul 27;170(3):414-427
pubmed: 28753422
Prog Mol Biol Transl Sci. 2020;169:297-321
pubmed: 31952690
Life Sci. 2010 Apr 10;86(15-16):590-7
pubmed: 19465029
Curr Neuropharmacol. 2006 Jul;4(3):239-57
pubmed: 18615144
Br J Pharmacol. 2006 Jan;147 Suppl 1:S163-71
pubmed: 16402100

Auteurs

Maria Gallo (M)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.

Estefanía Moreno (E)

Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.

Sira Defaus (S)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.

Antonio Ortega-Alvaro (A)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.

Angel Gonzalez (A)

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Patricia Robledo (P)

Integrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Marco Cavaco (M)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Vera Neves (V)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Miguel A R B Castanho (MARB)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Vicent Casadó (V)

Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.

Leonardo Pardo (L)

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.

Rafael Maldonado (R)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.

David Andreu (D)

Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, 08003 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

Classifications MeSH